REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • November 13th, 2024 • Oruka Therapeutics, Inc. • In vitro & in vivo diagnostic substances
This Registration Rights Agreement (this “Agreement”) is made and entered into as of August 29, 2024, among Oruka Therapeutics, Inc., a Delaware corporation (the “Company”), ARCA biopharma, Inc. (“Parent”), a Delaware corporation, and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).
